Friday, June 14, 2019Theatre CBasic Medical Sciences Building

Diet, Microbiome and Novel Treatments in GI Disease

P ROGRAMMORNING SESSION Morning session moderator: Laura Targownik

0825-0830 Welcome Charles Bernstein0830-900 Diet and IBD James Lewis0900-930 Predictors of Response to Therapies in IBD Siddharth Singh0930-1000 Manipulating the Gut Microbiome in IBD Dina Kao1000-1030 Sleep and its Impact on GI Disease Ali Keshavarzian1030-1050 break1050-1120 Marijuana and GI Disease Chris Andrews 1120-1220 Panel discussion Laura Targownik1220-1320 Lunch

AFTERNOON SESSIONAfternoon session moderator: Donald Duerksen

1320-1350 Manipulating the Gut Microbiome in IBS Mark Pimentel 1350-1420 Diet and IBS Eamonn Quigley1420-1440 Celiac Disease: Causes and Consequences Ben Lebwohl1440-1500 break1500-1530 Non-Responsive and Refractory Celiac Disease Alberto Rubio-Tapia1530-1600 Determining that your Patient is Adherent to a Gluten Free Diet Jocelyn Silvester1600-1700 Panel discussion Don Duerksen

Printing of this program was made possible by an unrestricted education grant from

AbbVie Canada Inc., Janssen Inc., Pfizer Canada Inc., Takeda Canada Inc. and Shire Canada

Diet, Microbiome and Novel Treatments in GI Disease

All Lectures will be 20 minutes with 10 minutes for discussion

FOR OUT-OF-TOWN GUESTS: Rooms have been set aside at:

The Fort Garry Hotel, Spa & Conference Centre222 Broadway, Winnipeg, MB R3C 0R3

Toll Free: 1 800 665 8088

Visit the website at www.fortgarryhotel.com

Please make your reservations prior to May 14, 2019Refer to Group Code: 1141ER

Supported by an unrestricted educational grant from AbbVie Canada Inc., Janssen Inc., Pfizer Canada Inc., Takeda Canada Inc. and Shire Canada

Scientific Organizer: Dr. Charles N. Bernstein Distinguished Professor of Medicine Section of Gastroenterology Director, University of Manitoba IBD Clinical and Research Centre Max Rady College of Medicine 804F-715 McDermot Avenue Winnipeg, MB R3E 3P4

Planning Committee: Section of Gastroenterology University of Manitoba All speakers have been asked to disclose all potential conflicts of interest

Place: Theatre C Basic Medical Sciences Building 730 William Avenue Winnipeg, MB R3E 0W3

Registration: Emma Shaw Section of Gastroenterology

Telephone: (204) 789-3369 Facsimile: (204) 789-3972 Email: emma.shaw@umanitoba.ca

Registration fees: Registration fee for practicing physicians $187.50 For payment of registration fee go to:

https://www.cpd-umanitoba.com/events/ gi-symposium-2019/

No charge for trainees, dieticians, nurses, allied health.

Cover page illustrated from a drawing by William Biddle,Held in the University of Manitoba, Faculty of Medicine, Dean’s Office

Chris Andrews, MD MSc FRCPC AGAFClinical Professor, Division of GastroenterologyCumming School of MedicineUniversity of Calgary – Calgary, AB

Dina Kao, MDAssociate ProfessorDepartment of MedicineDivision of GastroenterologyUniversity of Alberta - Edmonton, AB

Ali Keshavarzian, MD FRCP FACP AGAF MACGChair of Gastroenterology, Professor of Medicine, and the Graduate College Director of the Division of Digestive Diseases and NutritionDirector of the Institute for Advanced Study of the Gut, Chronobiology and InflammationRush University Medical Center - Chicago, Illinois

Ben Lebwohl, MD MSDirector of Clinical ResearchDirector of Quality Improvement, Division of Digestive and Liver DiseasesThe Celiac Disease Center at Columbia University – New York, NY

James Lewis, MD MSCEProfessor of Medicine and EpidemiologySenior Scholar in the Center for Clinical Epidemiology and BiostatisticsAssociate Director of the Inflammatory Bowel Disease programUniversity of Pennsylvania’s Perelman School of Medicine - Philadelphia, PA

Mark Pimentel, MD FRCP(C)Executive Director, Medically Associated Science and Technology (MAST) ProgramProfessor of Medicine Geffen School UCLAAssociate Professor, Cedars SinaiCedars-Sinai - Los Angeles, CA

Eamonn Quigley, MD FRCP FACP MACG FRCPIChair of Medicine in Digestive DisordersChief, Division of Gastroenterology and HepatologyMedical Director, Lynda K and David M Underwood Center for Digestive DisordersProfessor of Medicine, Weill Cornell Medical College Houston Methodist Hospital - Houston, TX

Alberto Rubio-Tapia, MDAssistant Professor of MedicineInternal Medicine/Gastroenterology and HepatologyClinician-InvestigatorMayo Clinic - Rochester, Minnesota

Siddharth Singh, MDAssistant Professor of Medicine in the Division of Gastroenterology Division of Biomedical Informatics at University of California San Diego UC San Diego School of Medicine – La Jolla - CA

Jocelyn Silvester, MD PhD FRCPCDirector of Research, Celiac Disease ProgramGastroenterology, Hepatology and NutritionBoston Children’s Hospital - Boston, MA

Donald Duerksen, MD, FRCPCMedical Director - Adult Manitoba Home Nutrition Program & WRHA Food and Nutrition ServicesSt. Boniface General Hospital, GI Site CoordinatorSt. Boniface General Hospital – Winnipeg, MB

Laura E. Targownik, MD, MSHS, FRCPC Section Head, Section of Gastroenterology, University of ManitobaGastroenterology and Endoscopy Site Lead, Health Sciences Centre Associate Director, University of Manitoba Inflammatory Bowel Disease Research CentreAssociate Professor, Department of Internal Medicine, Section of GastroenterologyCollege of Medicine, Faculty of Health Sciences, University of Manitoba

GUEST FACULTY:

Learning Objectives

All Lectures will be 20 minutes with 10 minutes for discussion

• To learn approach to managing diet in gastrointestinal diseases

• To learn how diet impacts on the gut microbiome and in turn gastrointestinal diseases

• To learn how treatments can impact on the gut microbiome and in turn impact on gastrointestinal diseases

• To learn predictors of response to medical therapies in IBD

• To understand how cannabinoids impact on health and gastrointestinal disease

• To understand how sleep disturbances can impact on gastro- intestinal diseases

• To understand the epidemiology of celiac disease

• To understand new treatments and alternative or adjunctive therapies to a GFD in celiac disease

• To learn how to determine that your patient is adherent to a gluten free diet

Through this program the CanMEDS roles of medical expert, communi-cator, collaborator, health advocate and scholar will be covered.

Section 1 programs approved by the CAG for MOC Section 1 credits are eligible for conversion to AMA PRA Category 1 Credits™.

This event is an accredited group learning activity (Section 1) as defined by the Maintenance of Certification program of the Royal College, approved by the Canadian Association of Gastroenterology (CAG).

LOCAL FACULTY: